1. Home
  2. BDRX vs LGVN Comparison

BDRX vs LGVN Comparison

Compare BDRX & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDRX
  • LGVN
  • Stock Information
  • Founded
  • BDRX 2000
  • LGVN 2014
  • Country
  • BDRX United Kingdom
  • LGVN United States
  • Employees
  • BDRX N/A
  • LGVN N/A
  • Industry
  • BDRX Biotechnology: Pharmaceutical Preparations
  • LGVN Medicinal Chemicals and Botanical Products
  • Sector
  • BDRX Health Care
  • LGVN Health Care
  • Exchange
  • BDRX Nasdaq
  • LGVN Nasdaq
  • Market Cap
  • BDRX 9.6M
  • LGVN 7.8M
  • IPO Year
  • BDRX N/A
  • LGVN 2021
  • Fundamental
  • Price
  • BDRX $1.06
  • LGVN $4.39
  • Analyst Decision
  • BDRX Strong Buy
  • LGVN Strong Buy
  • Analyst Count
  • BDRX 1
  • LGVN 1
  • Target Price
  • BDRX $8.00
  • LGVN $12.00
  • AVG Volume (30 Days)
  • BDRX 3.5M
  • LGVN 24.4M
  • Earning Date
  • BDRX 04-19-2024
  • LGVN 08-09-2024
  • Dividend Yield
  • BDRX N/A
  • LGVN N/A
  • EPS Growth
  • BDRX N/A
  • LGVN N/A
  • EPS
  • BDRX N/A
  • LGVN N/A
  • Revenue
  • BDRX $482,278.00
  • LGVN $978,000.00
  • Revenue This Year
  • BDRX N/A
  • LGVN $137.24
  • Revenue Next Year
  • BDRX N/A
  • LGVN $50.77
  • P/E Ratio
  • BDRX N/A
  • LGVN N/A
  • Revenue Growth
  • BDRX N/A
  • LGVN N/A
  • 52 Week Low
  • BDRX $0.67
  • LGVN $0.77
  • 52 Week High
  • BDRX $9.64
  • LGVN $37.50
  • Technical
  • Relative Strength Index (RSI)
  • BDRX 55.78
  • LGVN 71.83
  • Support Level
  • BDRX $0.71
  • LGVN $3.80
  • Resistance Level
  • BDRX $1.66
  • LGVN $6.40
  • Average True Range (ATR)
  • BDRX 0.12
  • LGVN 0.53
  • MACD
  • BDRX 0.02
  • LGVN 0.28
  • Stochastic Oscillator
  • BDRX 36.84
  • LGVN 59.31

About BDRX Biodexa Pharmaceuticals plc American Depositary Shs

Biodexa Pharmaceuticals Plc is a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines. The company combines approved and developed medications with its proprietary and innovative drug delivery technologies to provide compelling products that have the potential to powerfully impact the lives of patients.

About LGVN Longeveron Inc.

Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.

Share on Social Networks: